Skip to main content

Carr Financial Group Corp

Position in CHRS — Coherus Oncology, Inc.

CIK 1931232 WORCESTER, MA

Position in CHRS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$49,273
-$10,206 QoQ
Shares Held
35,195
0.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#71
of 147 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CHRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Carr Financial Group Corp holds $2,071,215 across 3 Biotechnology names. CHRS ranks #3 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 CHRS
Coherus Oncology, Inc.
This page
35,195 $49,273

All Filings in CHRS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,273 35,195
2026-03-31 $59,479 35,195
2025-12-31 $49,976 35,195
2025-09-30 $57,719 35,195
2025-06-30 $25,727 35,195
2025-03-31 $28,402 35,195
2024-12-31 $48,569 35,195
2024-09-30 $36,602 35,195
2024-06-30 $60,887 35,195
2024-03-31 $84,116 35,195
2023-12-31 $117,199 35,195